Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Nature reviews. Drug discovery, 2022-07, Vol.21 (7), p.482-483
[Peer Reviewed Journal]
Springer Nature Limited 2022. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-022-00030-4 ;PMID: 35145263
Full text available